Patent directory · USPTO A61K / A61P
Patents matching “VANDA PHARMACEUTICALS INC.”
96 pharma patents match "VANDA PHARMACEUTICALS INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 96 pharmaceutical patents matching "VANDA PHARMACEUTICALS INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11566011
Highly purified pharmaceutical grade tasimelteon
granted -
US 11549147
Treatment of atopic dermatitis with tradipitant
granted -
US 11458154
Treatment of CYR61- and VEGF-mediated conditions
granted -
US 11458116
Method of improving sleep
granted -
US 11433057
Method for improving or enhancing cognition
granted -
US 11324735
Method of treatment with tradipitant
granted -
US 11285129
Treatment of circadian rhythm disorders
granted -
US 11266622
Method of treatment
granted -
US 11202770
Liquid tasimelteon formulations and methods of use thereof
granted -
US 11203581
Highly purified pharmaceutical grade tasimelteon
granted -
US 11141400
Method of treatment
granted -
US 11090285
Treatment of circadian rhythm disorders
granted -
US 11078289
Cancer treatment
granted -
US 11071728
Treatment of schizophrenia
granted -
US 11060144
Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
granted -
US 11013713
Method of treatment
granted -
US 10987346
Iloperidone for the treatment of schizophrenia
granted -
US 10980770
Treatment of circadian rhythm disorders
granted -
US 10945988
Treatment of circadian rhythm disorders
granted -
US 10874659
Iloperidone metabolite for use in the treatment of psychiatric disorders
granted -
US 10829465
Highly purified pharmaceutical grade tasimelteon
granted -
US 10821099
Use of tradipitant in motion sickness
granted -
US 10772880
Method of treatment with tradipitant
granted -
US 10653665
Method of treatment
granted